Will all postinfarction patients receive defibrillators? Recent trials and expanding indications

Research output: Contribution to journalArticle

Abstract

Implantable defibrillators have been demonstrated to be the most effective therapy for secondary prevention of sudden cardiac death. Unfortunately, however, many patients succumb to their initial episode of cardiac arrest so that primary prevention strategies are warranted. Several studies have demonstrated the mortality benefit of prophylactic, implantable defibrillators in patients with coronary artery disease depressed ventricular function and nonsustained ventricular tachycardia with inducible ventricular tachycardia during electrophysiologic study. However, widespread application of this approach is limited by the need for invasive risk stratification. The results of the MADIT II study, which demonstrate mortality reduction with prophylactic ICD implantation in patients with previous myocardial infarction and severe left ventricular dysfunction in the absence of invasive risk stratification, have dramatic implications for the management of this high-risk population. This article will review these data and their implications.

Original languageEnglish (US)
Pages (from-to)360-363
Number of pages4
JournalInternational Congress Series
Volume1262
Issue numberC
DOIs
StatePublished - May 1 2004

Fingerprint

Defibrillators
Implantable Defibrillators
Ventricular Tachycardia
Ventricular Function
Mortality
Sudden Cardiac Death
Risk Management
Left Ventricular Dysfunction
Primary Prevention
Secondary Prevention
Heart Arrest
Coronary Artery Disease
Myocardial Infarction
Population
Therapeutics

Keywords

  • Congestive heart failure
  • Myocardial infarction
  • Sudden cardiac death
  • Ventricular fibrillation
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Will all postinfarction patients receive defibrillators? Recent trials and expanding indications. / Friedman, Paul Andrew.

In: International Congress Series, Vol. 1262, No. C, 01.05.2004, p. 360-363.

Research output: Contribution to journalArticle

@article{85d9ec6cbb974bc9b084abff718227f0,
title = "Will all postinfarction patients receive defibrillators? Recent trials and expanding indications",
abstract = "Implantable defibrillators have been demonstrated to be the most effective therapy for secondary prevention of sudden cardiac death. Unfortunately, however, many patients succumb to their initial episode of cardiac arrest so that primary prevention strategies are warranted. Several studies have demonstrated the mortality benefit of prophylactic, implantable defibrillators in patients with coronary artery disease depressed ventricular function and nonsustained ventricular tachycardia with inducible ventricular tachycardia during electrophysiologic study. However, widespread application of this approach is limited by the need for invasive risk stratification. The results of the MADIT II study, which demonstrate mortality reduction with prophylactic ICD implantation in patients with previous myocardial infarction and severe left ventricular dysfunction in the absence of invasive risk stratification, have dramatic implications for the management of this high-risk population. This article will review these data and their implications.",
keywords = "Congestive heart failure, Myocardial infarction, Sudden cardiac death, Ventricular fibrillation, Ventricular tachycardia",
author = "Friedman, {Paul Andrew}",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/j.ics.2004.02.010",
language = "English (US)",
volume = "1262",
pages = "360--363",
journal = "International Congress Series",
issn = "0531-5131",
publisher = "Elsevier BV",
number = "C",

}

TY - JOUR

T1 - Will all postinfarction patients receive defibrillators? Recent trials and expanding indications

AU - Friedman, Paul Andrew

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Implantable defibrillators have been demonstrated to be the most effective therapy for secondary prevention of sudden cardiac death. Unfortunately, however, many patients succumb to their initial episode of cardiac arrest so that primary prevention strategies are warranted. Several studies have demonstrated the mortality benefit of prophylactic, implantable defibrillators in patients with coronary artery disease depressed ventricular function and nonsustained ventricular tachycardia with inducible ventricular tachycardia during electrophysiologic study. However, widespread application of this approach is limited by the need for invasive risk stratification. The results of the MADIT II study, which demonstrate mortality reduction with prophylactic ICD implantation in patients with previous myocardial infarction and severe left ventricular dysfunction in the absence of invasive risk stratification, have dramatic implications for the management of this high-risk population. This article will review these data and their implications.

AB - Implantable defibrillators have been demonstrated to be the most effective therapy for secondary prevention of sudden cardiac death. Unfortunately, however, many patients succumb to their initial episode of cardiac arrest so that primary prevention strategies are warranted. Several studies have demonstrated the mortality benefit of prophylactic, implantable defibrillators in patients with coronary artery disease depressed ventricular function and nonsustained ventricular tachycardia with inducible ventricular tachycardia during electrophysiologic study. However, widespread application of this approach is limited by the need for invasive risk stratification. The results of the MADIT II study, which demonstrate mortality reduction with prophylactic ICD implantation in patients with previous myocardial infarction and severe left ventricular dysfunction in the absence of invasive risk stratification, have dramatic implications for the management of this high-risk population. This article will review these data and their implications.

KW - Congestive heart failure

KW - Myocardial infarction

KW - Sudden cardiac death

KW - Ventricular fibrillation

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=85022987458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022987458&partnerID=8YFLogxK

U2 - 10.1016/j.ics.2004.02.010

DO - 10.1016/j.ics.2004.02.010

M3 - Article

VL - 1262

SP - 360

EP - 363

JO - International Congress Series

JF - International Congress Series

SN - 0531-5131

IS - C

ER -